Argent BioPharma (MXC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MXC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Argent BioPharma’s ArtemiC™ Shows Promising Results in ARDS Treatment StudyAugust 25, 2025 | msn.comArgent Biopharma Announces Proposed Issue of 25 Million SecuritiesAugust 19, 2025 | msn.comArgent BioPharma strengthens clinical pipeline and EU reach with AusCann acquisitionAugust 19, 2025 | msn.comArgent secures deal for Malta manufacturing facility, unlocking US$1m in cost savingsApril 9, 2025 | msn.comArgent soars as cannabinoid-based epilepsy drug gains approval in GermanyApril 2, 2025 | msn.comArgent BioPharma’s Strategic Moves and CollaborationOctober 31, 2024 | markets.businessinsider.comArgent Biopharma Lists New Shares on ASXOctober 28, 2024 | markets.businessinsider.comArgent BioPharma Issues New Shares Amidst Strategic GrowthOctober 28, 2024 | markets.businessinsider.comArgent BioPharma Secures Funding for Drug DevelopmentOctober 24, 2024 | markets.businessinsider.comCo-Founder of Argent BioPharma Picks Up 3,721% More StockSeptember 15, 2024 | finance.yahoo.comMGC Pharmaceuticals rebrands as Argent BioPharma in strategic transformationApril 1, 2024 | msn.comMGC Pharmaceuticals Ltd: MGC Pharma Rebrands as Argent BioPharma in Strategic TransformationFebruary 13, 2024 | finanznachrichten.deMGC Pharma Rebrands as Argent BioPharma in Strategic TransformationFebruary 13, 2024 | finance.yahoo.comMGC Pharmaceuticals LtdFebruary 3, 2024 | afr.comMGC Pharma delighted with position after resetFebruary 2, 2024 | proactiveinvestors.com.auMGC Pharmaceuticals Ltd Stock (OTC:MGCLF), Analyst Ratings, Price Targets, PredictionsDecember 15, 2023 | benzinga.comMGC Pharmaceuticals Stock (OTC:MGCLF) Dividends: History, Yield and DatesDecember 15, 2023 | benzinga.comMGC Pharmaceuticals reshuffles board and appoints joint UK brokerNovember 30, 2023 | proactiveinvestors.comMGC Pharmaceuticals Ltd (MXCDA)November 15, 2023 | uk.investing.comMGC Pharmaceuticals reveals strategic objectives for H1 2024November 13, 2023 | proactiveinvestors.comMGC Pharmaceuticals hails pivot to medical products, legacy sales hitAugust 31, 2023 | au.investing.comMGC Pharmaceuticals closes SPP with funds to go toward production of cannabinoid medicinesAugust 29, 2023 | au.investing.comMGC Pharmaceuticals to "move forward and speak to the FDA"August 14, 2023 | proactiveinvestors.comMGC Pharma hits another milestone in path to FDA approval for anti-inflammatory CimetraAAugust 14, 2023 | msn.comMGC Pharmaceuticals proposes fundraising for Australian investorsAugust 1, 2023 | proactiveinvestors.comMGC Pharmaceuticals receives permission to import psilocybin mushrooms into...August 1, 2023 | proactiveinvestors.comMGC Pharmaceuticals gets first psilocybin import green light import for research facilityAugust 1, 2023 | proactiveinvestors.com.auMGC Pharmaceuticals receives permission to import psilocybin mushrooms into EuropeAugust 1, 2023 | finance.yahoo.comMGC Pharma nabs import approval for psilocybin to Slovenian research facilityJuly 31, 2023 | msn.comMGC Pharmaceuticals gets green light for first import of psilocybin to research facilityJuly 30, 2023 | au.investing.comMGC Pharmaceuticals Raises GBP650,000 via Heavily Discounted Placing, SubscriptionJuly 14, 2023 | marketwatch.comMGC Pharmaceuticals raises £0.7mln for working capitalJuly 14, 2023 | proactiveinvestors.comMGC Pharmaceuticals raises A$1.335 million for working capitalJuly 13, 2023 | proactiveinvestors.comMGC Pharmaceuticals clarifies shape of recent AMC Pharma orderJuly 12, 2023 | au.investing.comMGC Pharmaceuticals "pushing on" after signing fresh $1mln orderJuly 7, 2023 | proactiveinvestors.com.auMGC Pharmaceuticals "pushing on" after announcing fresh $1mln orderJuly 7, 2023 | proactiveinvestors.comMGC Pharma bags $1 million US orderJuly 7, 2023 | proactiveinvestors.com.auMGC Pharma bags US$1mln US orderJuly 7, 2023 | proactiveinvestors.comMGC Pharmaceuticals to "keep chipping away" after first CannEpil deliveryJune 2, 2023 | finance.yahoo.comMGC Pharmaceuticals delivers first CannEpil doses to UK patients; opens doors for refractory epilepsy treatmentJune 1, 2023 | proactiveinvestors.com.auMGC Pharmaceuticals appoints experienced life-sciences executive to boardJune 1, 2023 | proactiveinvestors.comInnovative Cannabis-Derived Epilepsy Treatment Reaches UK PatientsMay 31, 2023 | benzinga.comMGC Pharmaceuticals delivers first CannEpil® doses to UK patients; opens doors for refractory epilepsy treatmentMay 31, 2023 | proactiveinvestors.comFirst UK patients receive MGC Pharma’s CannEpil productMay 30, 2023 | msn.comMGC Pharmaceuticals announces boardroom changes, reflecting its shift of focusMay 30, 2023 | proactiveinvestors.comMXC.AX - MGC Pharmaceuticals LimitedMay 25, 2023 | au.finance.yahoo.comHealthcare stocks maintain clinical momentum in 2023’s March quarterMay 8, 2023 | proactiveinvestors.com.auMGC Pharma’s Malta facility is now GMP certified, opening door to markets such as the USMay 1, 2023 | msn.comMGC Pharmaceuticals to accelerate clinical pipeline developmentApril 27, 2023 | proactiveinvestors.comMGC Pharmaceuticals: Funding to progress CannEpil, CimetrA data soon - Proactive Research AnalystApril 21, 2023 | proactiveinvestors.com Get Argent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MXC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MXC Media Mentions By Week MXC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MXC News Sentiment▼0.000.71▲Average Medical News Sentiment MXC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MXC Articles This Week▼00▲MXC Articles Average Week Get the Latest News and Ratings for MXC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Argent BioPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MXC) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argent BioPharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXC Stock Alerts